SRF and familial dilated cardiomyopathy: Conversely, mice with AAV-SRF injection at postnatal one month exhibited severe DCM at 6 months, as evidenced by significantly reduced EF and FS, and increased LVIDs and ESV (Supplementary Figure S4).